Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$0.9 - $1.31 $28,937 - $42,120
-32,153 Closed
0 $0
Q3 2021

Jun 21, 2023

BUY
$1.21 - $1.61 $38,905 - $51,766
32,153 New
32,153 $41,000
Q3 2021

Mar 30, 2023

SELL
$1.21 - $1.61 $57,332 - $76,285
-47,382 Reduced 59.57%
32,153 $41,000
Q3 2021

Nov 15, 2021

SELL
$1.21 - $1.61 $57,332 - $76,285
-47,382 Reduced 59.57%
32,153 $41,000
Q2 2021

Jun 21, 2023

BUY
$1.6 - $2.02 $127,256 - $160,660
79,535 New
79,535 $129,000
Q2 2021

Mar 30, 2023

BUY
$1.6 - $2.02 $76,136 - $96,121
47,585 Added 148.94%
79,535 $129,000
Q2 2021

Aug 16, 2021

BUY
$1.6 - $2.02 $127,204 - $160,596
79,503 Added 248446.88%
79,535 $130,000
Q1 2021

Jun 26, 2023

BUY
$1.86 - $2.87 $59,427 - $91,696
31,950 New
31,950 $63.3 Million
Q1 2021

Mar 30, 2023

SELL
$1.86 - $2.87 $48,644 - $75,059
-26,153 Reduced 45.01%
31,950 $63,000
Q1 2021

May 14, 2021

SELL
$1.86 - $2.87 $108,012 - $166,663
-58,071 Reduced 99.94%
32 $63,000
Q4 2020

Jun 22, 2023

BUY
$1.65 - $2.43 $95,869 - $141,190
58,103 New
58,103 $120,000
Q4 2020

Mar 30, 2023

SELL
$1.65 - $2.43 $321 - $473
-195 Reduced 0.33%
58,103 $120,000
Q4 2020

Feb 16, 2021

SELL
$1.65 - $2.43 $321 - $473
-195 Reduced 0.33%
58,103 $120,000
Q3 2020

Jun 26, 2023

BUY
$1.6 - $2.35 $93,276 - $137,000
58,298 New
58,298 $99,000
Q3 2020

Mar 30, 2023

SELL
$1.6 - $2.35 $9,172 - $13,472
-5,733 Reduced 8.95%
58,298 $99,000
Q3 2020

Nov 13, 2020

SELL
$1.6 - $2.35 $9,172 - $13,472
-5,733 Reduced 8.95%
58,298 $100,000
Q2 2020

Jun 26, 2023

BUY
$1.33 - $2.76 $85,161 - $176,725
64,031 New
64,031 $148,000
Q2 2020

Mar 30, 2023

BUY
$1.33 - $2.76 $85,161 - $176,725
64,031 New
64,031 $148,000
Q2 2020

Aug 14, 2020

BUY
$1.33 - $2.76 $85,161 - $176,725
64,031 New
64,031 $149,000
Q3 2018

Nov 14, 2018

SELL
$1.06 - $1.69 $55,069 - $87,798
-51,952 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$0.91 - $2.24 $47,276 - $116,372
51,952 New
51,952 $0
Q4 2017

Feb 15, 2018

SELL
$0.78 - $2.1 $74,617 - $200,892
-95,663 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$1.55 - $1.82 $148,277 - $174,106
95,663
95,663 $169,000

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $173M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.